Table 3.
Diagnostic performances of ZJU, VAI, HSI, LAP, and FLI for detecting MAFLD.
| AUROC (95% CI) | p-Value | Sensitivity (%) | Specificity (%) | Cut-Off Value | |
|---|---|---|---|---|---|
| ZJU | 0.704 (0.675–0.734) | <0.0001 | 66.4 | 66.5 | 231.1261 |
| VAI | 0.705 (0.675–0.735) | <0.0001 | 66.0 | 65.8 | 142.9275 |
| HSI | 0.784 (0.758–0.809) | <0.0001 | 71.5 | 70.9 | 33.2182 |
| LAP | 0.747 (0.720–0.775) | <0.0001 | 68.9 | 68.2 | 2278.3 |
| FLI | 0.791 (0.766–0.816) | - | 70.9 | 70.9 | 29.9358 |
p-values were calculated for ZJU, VAI, HSI, and LAP compared to FLI. MAFLD, metabolic dysfunction-associated fatty liver disease; AUROC, area under the receiver operating characteristic curve; CI, confidence interval; ZJU, Zhejiang University index; VAI, visceral adiposity index; HSI, hepatic steatosis index; LAP, lipid accumulation product; FLI, fatty liver index.